選材

只有登錄於MEDLINE、EMBASE和CENTRAL數據庫中,並經同行評議的隨機對照試驗和系統性文獻回顧會被納入本網站中。

編寫和證據分級

雖然隨機對照試驗和系統性文獻回顧的報告非常容易取得,但現有的實施研究(implementation research)顯示應用其結果於協助臨床決策並不理想[1]。搜索、識別和檢索循證醫學的資源是可以很耗時的,而且這被認為是醫師解答臨床問題時的障礙[2]。以使用者友善格式去再現隨機對照試驗和系統性文獻回顧的關鍵內容可以有效促進醫療專業人員有效地利用證據[3],而《證視中西醫理》旨在將這種概念引入結合醫學的領域上。每個概要的證據質量均使用Chinese and Integrative Medicine Evidence RAting System (CHIMERAS)評估,該系統將證據質量分級為非常高到非常低。

有關CHIMERAS的更多資料,請參閱:Chung, V. C., Wu, X. Y., Ziea, E. T., Ng, B. F., Wong, S. Y., & Wu, J. C. (2015). Assessing internal validity of clinical evidence on effectiveness of CHinese and integrative medicine: Proposed framework for a CHinese and Integrative Medicine Evidence RAting System (CHIMERAS). European Journal of Integrative Medicine, 7(4), 332-341.

 

參考文獻

1 - Wallace, John, Bosah Nwosu, and Mike Clarke. "Barriers to the uptake of evidence from systematic reviews and meta-analyses: a systematic review of decision makers’ perceptions." BMJ open 2.5 (2012): e001220.

2 - Coumou, Herma CH, and Frans J. Meijman. "How do primary care physicians seek answers to clinical questions? A literature review IRP." Journal of the Medical Library Association 94.1 (2006): 55.

3 - Alper, Brian S., and R. Brian Haynes. "EBHC pyramid 5.0 for accessing preappraised evidence and guidance." Evidence Based Medicine 21.4 (2016): 123-125.